Precise targeting and maintenance of axonal domains in myelinated axons is essential for saltatory conduction. Caspr and Caspr2, which localize at paranodal and juxtaparanodal domains, contain binding sites for the cytoskeletal adaptor protein 4.1B. The exact role of 4.1B in the organization and maintenance of axonal domains is still not clear. Here, we report the generation and characterization of 4.1B-null mice. We show that loss of 4.1B in the PNS results in mislocalization of Caspr at paranodes and destabilization of paranodal axoglial septate junctions (AGSJs) as early as postnatal day 30. In the CNS, Caspr localization is progressively disrupted and ultrastructural analysis showed paranodal regions that were completely devoid of AGSJs, with axolemma separated from the myelin loops, and loops coming off the axolemma. Most importantly, our phenotypic analysis of previously generated 4.1B mutants, used in the study by Horresh et al. (2010), showed that Caspr localization was not affected in the PNS, even after 1 year; and 4.1R was neither expressed, nor enriched at the paranodes. Furthermore, ultrastructural analysis of these 4.1B mutants showed destabilization of CNS AGSJs at ϳ1 year. We also discovered that the 4.1B locus is differentially expressed in the PNS and CNS, and generates multiple splice isoforms in the PNS, suggesting 4.1B may function differently in the PNS versus CNS. Together, our studies provide direct evidence that 4.1B plays a pivotal role in interactions between the paranodal AGSJs and axonal cytoskeleton, and that 4.1B is critically required for long-term maintenance of axonal domains in myelinated axons.
Introduction
A fundamental characteristic of myelinated axons is their organization into distinct molecular domains that allows for saltatory action potential propagation. These domains include nodes, where voltage-gated sodium channels are enriched; paranodes, where myelin loops establish axoglial septate junctions (AGSJs) with the axolemma; and juxtaparanodes, where delayed-rectifier potassium channels are clustered (Bhat, 2003; Salzer, 2003; Thaxton and Bhat, 2009; Thaxton et al., 2011) . Genetic ablation of Caspr resulted in loss of paranodal AGSJs and disorganization of the paranodal axonal cytoskeleton (Bhat et al., 2001; GarciaFresco et al., 2006) . Disruption of paranodal AGSJs in Cgt, Caspr, Cont, and Nfasc NF155 mutants permitted juxtaparanodal components to move alongside nodal sodium channels, indicating that AGSJs serve a fence function at paranodes (Rosenbluth, 1988; Dupree et al., 1999; Bhat et al., 2001; Boyle et al., 2001; Pillai et al., 2009) . Another member of the Caspr family, Caspr2, is required for the organization of the juxtaparanodal domain and localization of potassium channels (Poliak et al., 2003) . The stabilization of Caspr and Caspr2, and their associated complexes, is thought to depend on cytoskeletal adaptor proteins that link these complexes with axonal and glial cytoskeleton for their long-term stability.
It was reported that the extracellular domain of Caspr is sufficient for membrane targeting, whereas the intracellular domain is required for Caspr stabilization at the paranodes (Gollan et al., 2002) . Both Caspr and Caspr2 contain 4.1-binding sequences, suggesting that their interactions may be physiologically relevant (Girault et al., 1998; Denisenko-Nehrbass et al., 2003) . Several members of the 4.1 protein family are expressed in the nervous system (Yamakawa et al., 1999; Ohara et al., 2000; Parra et al., 2000) . Only 4.1B is enriched at paranodes and juxtaparanodes in myelinated axons (Ohara et al., 2000; Denisenko-Nehrbass et al., 2003) . The presence of a 4.1/ezrin/radixin/moesin (FERM) and a spectrin-actin binding domain make 4.1B an ideal candidate to link Caspr and Caspr2-dependent complexes with the underlying axonal cytoskeleton. Disruption of paranodal AGSJs in Caspr and Cont mutants alters 4.1B localization (Gollan et al., 2002; GarciaFresco et al., 2006) . However, Caspr2 mutants showed normal 4.1B localization (Traka et al., 2003) . Recent studies showed that loss of 4.1B does not affect paranodal Caspr localization in sciatic nerves; and in vivo deletion of 4.1B-binding region in Caspr and Caspr2 did not affect Caspr localization, but affected Caspr2 localization (Horresh et al., 2010) .
Here, we report that 4.1B is essential for proper Caspr localization and maintenance of the paranodal and juxtaparanodal domains. We demonstrate that loss of 4.1B leads to destabilization of AGSJs at the paranodes and complete disorganization of the juxtaparanodal complexes. We also show that 4.1B mutants generated previously (Yi et al., 2005) have proper localization of paranodal proteins even after 1 year in the PNS, and that 4.1R is not involved in paranodal organization or rescue of 4.1B mutant paranodes. Together, our results establish an important role of 4.1B as a cytoskeletal adaptor protein that links axoglial junctional complexes with axonal cytoskeleton to ensure long-term stability and maintenance of axonal domains in myelinated axons.
Materials and Methods
Animals. All animal experiments were performed according to University of North Carolina Institutional Animal Care and Use Committeeapproved guidelines for ethical treatment of laboratory animals. 4.1B/ Epb4.1l3 knock-out mice described previously (Yi et al., 2005) and transgenic mice expressing Cre recombinase under the ubiquitous ␤-Actin promoter (␤-Actin-Cre) were purchased from The Jackson Laboratory.
Generation of 4.1B/Epb4.1l3 conditional mutants. The 4.1B/Epb4.1l3 locus spans ϳ133 kb of genomic DNA and generates several alternatively spliced mRNAs (see www.ensembl.org/Mus_musculus). To conditionally ablate the 4.1B gene, a targeting construct was generated in which loxP sites were targeted to flank exon 6. Using BAC recombineering technology, a BAC clone pBACe3.6 from 129 AB2.2 BAC library containing the 4.1B locus was targeted such that a neo cassette flanked by FRT, FRT-loxP sites was inserted in intron 5 and a second loxP site was inserted in intron 6. Before ES cell targeting, the functionality of the loxP sites, as well as the expected restriction enzyme digestion patterns in the targeting vector, were confirmed. The targeting construct was linearized with NotI followed by electroporation into ES cells. The targeted ES cells were screened by Southern blotting with a 500 bp probe upstream of the targeting vector in the 4.1B gene. Two independent targeted clones were used for generating 4.1B-floxed mice using standard procedures.
Generation of 4.1B antibodies. cDNA sequences encoding a portion of the U3 domain of 4.1B (amino acids 655-793) were PCR amplified from a mouse cDNA library, cloned into pET28(aϩ) vector (Novagen), and expressed in Escherichia coli BL21(DE3). The recombinant protein was purified over a Ni-Sepharose column and used as an antigen to immunize rabbits and guinea pigs, as described previously (Bhat et al., 2001) .
Tissue preparation, antibodies, and immunostaining. The following antisera were previously described: guinea pig and rabbit anti-Caspr (Bhat et al., 2001; Pillai et al., 2009; Thaxton et al., 2010) , guinea pig anti-NF186 and rat anti-pan Neurofascin (Pillai et al., 2009; Thaxton et al., 2010) , rat anti-Ankyrin G (AnkG) and rabbit anti-Caspr2 (Thaxton et al., 2010) , rabbit polyclonal anti-4.1R and 4.1N (Kang et al., 2009) , and rabbit and guinea pig anti-4.1B antibodies (this study). Other primary antibodies used include the following: mouse anti-K v 1.1 (University of California Davis/NIH NeuroMab Facility; K20/78), mouse anti-K v 1.2 (University of California Davis/NIH NeuroMab Facility; K14/16), mouse anti-PSD95 (University of California Davis/NIH NeuroMab Facility; K28/ 43), and rabbit anti-␣-Tubulin (Tub) (Cell Signaling). Secondary antibodies used for immunofluorescence were Alexa Fluor-488, -568, and -647 conjugated (Invitrogen). The HRP-conjugated secondary antibodies were purchased from Jackson ImmunoResearch.
Tissues used for immunostaining were prepared as previously described (Thaxton et al., 2010) . Briefly, sciatic nerves were removed from anesthetized littermate wild type and mutants of either sex and fixed in 4% paraformaldehyde in PBS for 30 min at 4°C. The nerves were washed with PBS several times and either stored at 4°C or immediately teased. The nerves were teased into individual fibers in PBS, mounted on glass slides, and dried overnight at room temperature, followed by storage at Ϫ80°C or immediate processing by treatment with acetone at Ϫ20°C for 20 min and several washes with PBS, followed by immunostaining. For spinal cord sections, wild type and mutants of either sex were deeply anesthetized and transcardially perfused with saline buffer followed by ice-cold 4% paraformaldehyde in PBS. The spinal cord was dissected out and postfixed in 4% paraformaldehyde overnight at 4°C. The tissues were rinsed several times in PBS and sectioned to 30 m using a Vibratome (Leica). The spinal cord sections were then immediately immunostained as previously described (Garcia-Fresco et al., 2006; Pillai et al., 2009) .
RNA preparation and RT-PCR. DRGs from ␤-Act-Cre;4.1B Flox , 4.1B Ϫ/Ϫ , and control littermate mice of either sex were collected and simultaneously processed in RNAlater Stabilization Reagent (QIAGEN). Total RNA was isolated using QIAshredder columns (QIAGEN) and RNeasy Mini Kit (QIAGEN). RNA concentration was estimated and equal amounts of RNA were used for reverse transcription followed by PCR amplification using the MyTaq One-Step RT-PCR kit (Bioline). Primers used for PCR were as follows: 4.1B, 5Ј-CTGGTT-GGACCCTGCTAAGG-3Ј and 5Ј-CTTGGCATGGTGTAAGTCC-3Ј; 4.1R, 5Ј-AAGAGTTTAGCGGCTGAAGC-3Ј and 5Ј-CGGGCTTCTGGGA-GGCTT-3Ј; and Actin, 5Ј-GCTCCGGCATGTGCAA-3Ј and 5Ј-AGGATCTTCATGAGGTAGT-3Ј.
Immunoblotting and immunoprecipitation. Sciatic nerves from littermate wild type and mutants of either sex were excised and crushed using a glass homogenizer in ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM EDTA, 1% Triton X-100, 1% SDS, and a protease mixture tablet). The lysate was incubated on ice for 30 min and centrifuged at 16,000 ϫ g for 20 min at 4°C. The supernatant was used for protein estimation and immunoblotting.
Spinal cords from littermate wild type and mutants of either sex were excised and either directly processed or frozen at Ϫ80°C. Spinal cords were homogenized using a glass mortar and pestle on ice with 1 ml of ice-cold homogenization buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 320 mM sucrose, 10 mM EDTA, pH 8.0, and a protease inhibitor mixture tablet). The homogenate was centrifuged at 1000 ϫ g for 10 min at 4°C. The supernatant was collected and subjected to additional centrifugation at 100,000 ϫ g for 30 min at 4°C. The resulting pellet was then resuspended in lysis buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl, 10 mM EDTA, 1% Triton X-100, and a protease inhibitor mixture tablet) and incubated for 30 min at 4°C with occasional trituration followed by centrifugation at 100,000 ϫ g for 30 min at 4°C and the supernatant was collected as the final lysate. Protein concentrations of the lysate were determined using the Lowry assay (BC assay; Bio-Rad).
For immunoprecipitation (IP), immobilized protein A-Sepharose beads (Thermo Fisher Scientific) were washed with PBS and incubated with either primary antibodies for 2-4 h at 4°C (antibody-bound beads) or 500 g of total protein for 1-2 h at 4°C (preclear beads). The antibodybound beads were washed once, and the lysate from the preclear beads was added and rotated overnight at 4°C. After brief centrifugation, the supernatant was collected as the post-IP material. The preclear and IP beads were washed three times with wash buffer (50 mM Tris-HCl, pH 7.5, 50 mM NaCl). Lysate, preclear beads, IP beads, and post-IP material were resolved by SDS-PAGE and transferred onto nitrocellulose membranes, followed by immunoblotting procedures described above.
Transmission electron microscopy. Transmission electron microscopy of age-matched wild-type, ␤-Act-Cre;4.1B Flox , and 4.1B Ϫ/Ϫ mutant mice of either sex was performed essentially as described previously (GarciaFresco et al., 2006; Pillai et al., 2009; Thaxton et al., 2010) .
Image analysis. Confocal images were captured with a Bio-Rad Radiance 2000 laser-scanning system attached to a Zeiss Axioplan2 microscope. Scanning parameters were optimized for wild-type tissues and maintained for scanning the mutant tissues. The immunofluorescence images shown are Z stacks of four to eight sections with a scan step of 0.25 m. Adobe Photoshop was used for assembling all figures.
Results
Developmental expression of 4.1B and generation of 4.1B-null mutants Members of the 4.1 protein family are cytoskeletal adaptors that link membrane proteins to the underlying cytoskeleton (Peters et al., 1998; Hoover and Bryant, 2000) . 4.1B, a member of this family, is expressed in the nervous system and is highly enriched at the paranodal and juxtaparanodal domains in myelinated axons (Ohara et al., 2000) . Based on 4.1B subcellular localization and its binding with Caspr and Caspr2 (Ohara et al., 2000; DenisenkoNehrbass et al., 2003) , it was hypothesized that 4.1B links axoglial junctions or scaffolds with the axonal cytoskeleton. The primary structure of 4.1B contains a FERM domain, a spectrin/actin binding domain (SAB), a C-terminal domain (CTD), and three unique regions U1-U3 (Fig. 1 A) . We generated antibodies to the U3 unique region of 4.1B ( Fig. 1 A, black bar) and performed immunostaining of teased sciatic nerve fibers (PNS) and spinal cord sections (CNS) to establish the subcellular localization of 4.1B in the PNS and CNS (Fig. 1 B, C) . As shown in Figure 1 B, 4.1B is enriched at the paranodes and juxtaparanodes (Fig. 1 Ba, red arrows) and overlaps with the paranode-specific protein, Caspr (Fig. 1 Bb) . A merged image (Fig. 1 Bc) clearly shows that 4.1B is enriched in the juxtaparanodal region (red arrow) and is not expressed at the nodes ( Fig. 1 Bc, arrow) . Similarly, in the CNS, 4.1B is enriched at the paranodes and juxtaparanodes but is not present at the nodes (Fig. 1Ca-c) . To determine when 4.1B expression begins during postnatal development, we performed immunoblot analysis of 4.1B from postnatal day 2 (P2) to P24 (Fig. 1 D) . This revealed that two major isoforms of 4.1B (145 and 125 kDa) are expressed in the spinal cord throughout early postnatal development. We immunoblotted the lysates against Caspr, which revealed that Caspr is also expressed throughout postnatal development, as has been reported previously (Bhat et al., 2001) .
4.1B mouse mutants have been previously generated using conventional methods (Yi et al., 2005) . As these presumed 4.1B-null mutants did not reveal any developmental or behavioral deficits, concerns were raised whether some 4.1B protein isoforms might still be expressed from the disrupted 4.1B locus. To address this issue, we took advantage of the detailed 4.1B genomic information to generate a floxed allele of 4.1B that would essentially ablate all isoforms of 4.1B on Cre-mediated recombination ( Fig. 1 E) (see Materials and Methods). A targeting construct was generated in which exon 6 (which encodes a portion of the FERM domain) was flanked with loxP sites (Fig. 1 E) and deletion of exon 6 would cause a frameshift resulting in a premature stop codon in exon 7 ( Fig. 1 E, red asterisk) . ES cell clones that carried a properly targeted 4.1B floxed allele were identified by Southern analysis (Fig. 1 F) . After germ line transmission, mice were genotyped using a combination of primers ( Fig. 1 E) , which revealed various genotypes (Fig. 1G ). Homozygous 4.1B Flox mice were born with expected Mendelian frequency and did not reveal any obvious behavioral or development deficits (data not shown). After Cre-mediated recombination using the ubiquitous ␤-Actin-Cre (Act-Cre), littermate mice with wild-type (ϩ/ϩ) or ␤-Act-Cre;4.1B Flox genotype were analyzed by immunoblotting. As shown in Figure 1 H, spinal cord lysates from ␤-Act-Cre; 4.1B Flox show complete loss of 145 and 125 kDa 4.1B protein isoforms, which were present in the wild-type lysates, indicating that 4.1B was ablated in ␤-Act-Cre;4.1B Flox mice. To ensure that 4.1B was also absent in the PNS myelinated axons, we performed immunostaining against 4.1B, paranodal Caspr, and nodal Ankyrin G (ANK) in teased sciatic nerves from littermate wildtype (ϩ/ϩ) and ␤-Act-Cre;4.1B Flox mice ( To further confirm that this altered Caspr localization reflected a disorganization of other paranodal proteins, we immunostained ␤-Act-Cre;4.1B Flox sciatic nerve fibers against Neurofascin (NFAS) (which recognizes both NF155 and NF186), Caspr, and ANK. The wild-type fibers revealed a typical paranodal localization of NF155 ( Fig. 1 Ka, NFAS, green arrowheads) and Caspr ( Fig. 1 Kb, red arrowheads) at the paranodes and ANK (Fig. 1 Kc, d, blue, arrow) at the nodes and all in the merged image ( Fig.  1 Kd). In ␤-Act-Cre;4.1B Flox sciatic nerve fibers, both Caspr and NF155 localization at the paranodes was disrupted, and their distribution stretched away from the paranodes (Fig. 1 La, b, d, asterisks) . The ANK localization was normal at the nodes ( 
4.1B is required for the organization and stabilization of the paranodal and juxtaparanodal regions in myelinated axons
To determine the consequences of loss of 4.1B on axonal domain organization, we decided to analyze both 4.1B mutants [i.e., ␤-Act-Cre;4.1B Flox (this study) and 4.1B Ϫ/Ϫ generated previously (Yi et al., 2005) ]. To date, no detailed phenotypic characterization of myelinated axons in any 4.1B mutants has been performed. In this study, we examined the localization of well characterized paranodal and juxtaparanodal proteins in teased sciatic nerve fibers and spinal cord sections (Figs. 2, 3 ). In wildtype (ϩ/ϩ) sciatic nerve fibers, 4.1B is enriched at the paranodes and juxtaparanodes and also localizes along the length of the internode (Fig. 2 Aa, red). Caspr served as a marker for the para- Caspr (Fig. 2Cb, d; Fb, d; Hb, d, asterisks) and NF155 (Fig. 2 Ha,d, arrowhead) localization at the paranodes in 4-month-old ␤-Act-Cre;4.1B Flox sciatic nerves were relatively more compact than at 1 month, but still contained broken and disrupted areas (Hd, arrowhead). These results indicate that loss of 4.1B affects juxtaparanodal organization and proper localization of axoglial junctional components at the paranodes (Table 1) .
Next, we examined localization of paranodal Caspr, juxtaparanodal K V 1.1, and nodal ANK in the sciatic nerves of 3 (Yi et al., 2005) . As expected, 4.1B is absent at the paranodes and juxtaparanodes in 4.1B Ϫ/Ϫ mutant fibers (Fig. 2 Ja, red) . Interestingly, as observed by Horresh et al. (2010), Caspr (Fig. 2 Jb,d; Lb,d, green) localization at the paranodes was not affected in 4.1B Ϫ/Ϫ mutant fibers. K V 1.1 localization at the juxtaparanodes is compromised in 4.1B Ϫ/Ϫ mutants (Fig. 2 La,d, red, asterisks), as is also seen in ␤-Act-Cre;4.1B Flox mutants (Fig. 2 Ea, d; Fa, d, red) . In addition, K v 1.2, Caspr2, and PSD95 were similarly mislocalized from the juxtaparanodes (data not shown). These data indicate that, in 4.1B Ϫ/Ϫ mutants, localization of the juxtaparanodal proteins is compromised, whereas the paranodal components are not affected (Table 1) .
We also analyzed the localization of paranodal and juxtaparanodal proteins in the spinal cords of ␤-Act-Cre;4.1B Flox and 4.1B Ϫ/Ϫ mutants. In wild-type (ϩ/ϩ) spinal cord sections, 4.1B is enriched at the paranodes and the juxtaparanodes (Fig. 3Aa,   red ). In addition, Caspr (Fig. 3Ab ,Db, green), AnkG (Fig. 3Ac, blue) , and NF186 (Fig. 3Dc, blue) are localized at the paranodes and nodes, respectively (Fig.  3Ad,Dd) . As in the PNS, 4.1B is absent in 1-and 4-month-old ␤-Act-Cre;4.1B Flox spinal cord myelinated axons (Fig.  3Ba,Ca, red) . However, the paranodal localization of Caspr ( Fig. 3Bb,d ;Eb,d, green) was not disrupted in 1-month-old ␤-Act-Cre;4.1B Flox spinal cord axons. Interestingly, in 4-month-old ␤-Act-Cre; 4.1B Flox spinal cord myelinated axons, Caspr ( Fig. 3Cb,d ;Fb,d, green) localization was not normal. There were gaps between paranodal Caspr and the nodal proteins AnkG and NF186 ( Fig. 3Cc,d ; Fc,d, arrowheads) . Again, the juxtaparanodal K v 1.2 was mislocalized in both 1-and 4-month-old ␤-Act-Cre;4.1B Flox mutant spinal cord axons ( Fig. 3Ea,d ;Fa,d, red, asterisks). AnkG and NF186 were both maintained at the nodes in all ␤-Act-Cre; 4.1B Flox mutants ( Fig. 3Bc,d (Fig.  3Ha, red) . Paranodal Caspr localization remained relatively unaffected (Fig. 3Hb-,d ;Jb,d, green). The juxtaparanodal K v 1.1 was mislocalized (Fig. 3Ja,d , red, arrowheads). Nodal AnkG (Fig. 3Hc,d , blue) and NF186 (Fig. 3Jc,d, blue) were not affected. The juxtaparanodal proteins K v 1.2, PSD95, and Caspr2 were similarly mislocalized in the spinal cords of both 4.1B mutants (data not shown). Together, the immunohistochemical results indicate that 4.1B is critical for proper organization of the juxtaparanodal region in both the PNS and the CNS, and that 4.1B is required for the stabilization of the paranodes in the PNS, and progressively in the CNS (Table 1) .
Molecular interactions between
paranodal Caspr and complex formation between juxtaparanodal Caspr2, K v 1.2, and 4.1B To further investigate the striking phenotypic differences between the PNS and CNS myelinated fibers, we immunoblotted sciatic nerve and spinal cord lysates from wild type (ϩ/ϩ), 4.1B Ϫ/Ϫ , and ␤-Act-Cre;4.1B Flox mutants (Fig. 4 A, B) . Surprisingly, we discovered that the wild-type sciatic nerves express close to eight isoforms of 4.1B, some with molecular weights exceeding 180 kDa, in contrast to the CNS, where only two major isoforms (145 and 125 kDa) are expressed (Fig. 4 , compare Aa, Ba). All of these 4.1B isoforms were absent in both 4.1B mutants (Fig.  4 Aa,Ba). Immunoblotting against Caspr did not reveal any significant changes in the relative Caspr levels between wild-type and 4.1B mutants (Fig. 4 Ab,Bb). In addition, immunoblotting against juxtaparanodal proteins K v 1.2 and Caspr2 did not reveal any significant differences in their levels between the wild-type and 4.1B mutant sciatic nerves (Fig. 4 Ac,d ). For protein loading Flox (Ba-Bd, Ea-Ed), and 4-month-old ␤-Act-Cre;4.1B Flox (Ca-Cd, FaFd, Ha-Hd) sciatic nerve fibers immunostained against 4.1B (Aa, Ba, Ca, red), K v 1.1 (Da, Ea, Fa, red), Caspr (Ab-Hb, green), pan-NFAS (Ga, Ha), AnkG (Ac-Cc, blue), NF186 (Dc-Hc, blue), and merged images (Ad-Hd). Note that 4.1B is absent from the mutant fibers (Ba, Ca) and K v 1.1 (Ea, Ed; Fa, Fd) is either undetectable at the juxtaparanodes or severely mislocalized. In all 4.1B mutant panels, Caspr (Bb, Bd; Cb, Cd; Eb, Ed; Fb, Fd; Hb, Hd, asterisks) and paranodal NF155 (NFAS) (Ha, Hd, arrowhead) fail to localize properly at the paranodes. Nodal AnkG or NF186 are not affected (Ac,d-Hc,d, arrows) . I-L, P90 wild-type (ϩ/ϩ) (Ia-Id, Ka-Kd) and 4.1B Ϫ/Ϫ (Yi et al., 2005 ) (Ja-Jd, La-Ld) sciatic nerve fibers immunostained against 4.1B (Ia, Ja, red), K v 1.1 (Ka, La, red), Caspr (Ib-Lb, green), AnkG (Ic, Jc, blue), NF186 (Kc, Lc, blue), and merged images (Id-Ld). 4.1B is absent from the mutant fibers, as expected (Ja, Jd), and K v 1.1 is either undetectable at the juxtaparanodes or severely mislocalized (La, Ld, asterisks). However, Caspr localizes properly at the paranodes (Jb, Jd; Lb, Ld, asterisks). Nodal AnkG or NF186 are not affected (Jc, Jd; Kc, Kd; Lc, Ld, arrows). Scale bars, 10 m (all).
control, membranes were immunoblotted against Tub (Fig.  4 Ae,Bc). We also wanted to determine whether disruption of the paranodal axoglial junctions in Caspr (Bhat et al., 2001) and Cgt (Dupree et al., 1999 ) mutants affected 4.1B protein levels in the spinal cords. As shown in Figure 4Ca , 4.1B protein levels are relatively unchanged between wild-type and the paranodal mutants. Similarly, Caspr levels are not affected in 4.1B and Cgt mutant spinal cords (Fig. 4Cb) . For protein loading control, membranes were immunoblotted against ␣-Tubulin (Fig. 4Cc) . These data show that sciatic nerves express multiple forms of 4.1B and that loss of 4.1B or Caspr only affects the subcellular localization of Caspr and 4.1B, respectively, and that stable expression of each of these proteins is not dependent on the other paranodal proteins.
Our immunohistochemical data showed that 4.1B is required for the localization of potassium channels K v 1.1 and Caspr2 to the juxtaparanodal region (Figs. 2, 3) . Previous studies revealed that a possible mechanism for potassium channel retention at the juxtaparanodal region could be attributable to molecular interactions between Caspr2 and potassium channels (Poliak et Figure  4 D, a and b, immunoprecipitation with anti-Caspr antibodies using spinal cord lysates coprecipitated 4.1B. Additionally, in the wild-type spinal cord lysates, IPs with anti-Caspr2 antibodies coprecipitated potassium channels K v 1.2 (Fig.  4 Ea,aЈ). Caspr2 and K v 1.2 still formed a molecular complex in the absence of 4.1B in ␤-Act-Cre;4.1B Flox (Fig. 4 Eb,bЈ) and 4.1B Ϫ/Ϫ (Fig. 4 Ec,cЈ) spinal cord lysates. These results suggest that 4.1B is critical for the maintenance of the juxtaparanodal complex of Caspr2 and potassium channels and not the formation of this molecular complex. Together, our results demonstrate that 4.1B is a critical component of the paranodal and juxtaparanodal domains and that expression of multiple isoforms in the PNS versus the CNS may allow for differential function of 4.1B in axonal domain organization.
4.1B is critical for the stability of the paranodal axoglial septate junctions
Our immunofluorescence studies revealed striking juxtaparanodal disorganization in both the PNS and the CNS in ␤-Act-Cre;4.1B Flox and 4.1B Ϫ/Ϫ mutants (Figs. 2, 3 ). In addition, we found severe paranodal destabilization in the PNS, and progressive paranodal disruption in the CNS, of ␤-Act-Cre;4.1B Flox mice (Fig. 3) . To further investigate the role of 4.1B in axonal domain organization, we used electron microscopy to specifically look at the ultrastructural architecture of the paranodal region in wild-type, ␤-Act-Cre;4.1B Flox , and 4.1B Ϫ/Ϫ mutant sciatic nerve and spinal cord myelinated axons (Figs. 5, 6) . A low-magnification electron micrograph of P30 littermate wild-type (ϩ/ϩ) ( Fig. 5A ) and ␤-Act-Cre;4.1B Flox mutant (Fig.  5B ) sciatic nerve myelinated axons, at the level of the nodal/ paranodal region, shows a typical domain distinction between the nodal and the paranodal region. At this magnification, the wild-type and ␤-Act-Cre;4.1B Flox mutant fibers look essentially similar with respect to the presence of individual domains. At a higher magnification, the paranodal AGSJs show characteristic electron-dense septa between the myelin loops and the axolemma in wild-type fibers (Fig. 5C, arrowheads) . In 1-month-old ␤-Act-Cre;4.1B Flox mutant fibers, a few electron-dense septa can be found (Fig. 5D, arrowhead) , whereas most septa appear diffuse and ill defined (Fig. 5D, asterisks) , suggesting that septa may be undergoing destabilization. In 3-month-old ␤-Act-Cre;4.1B Flox mutant fibers, the electron density of the septa is diffuse and fuzzy (Fig. 5 E, F, asterisks) . In comparison, ultrastructural analysis of previously generated 4.1B Ϫ/Ϫ mutants revealed no clear differences in the ultrastructural morphology of the paranodal axoglial septa at 3 months ( Fig. 5H; compare with G, arrowheads) . However, at 6 month and 1 year time points, septa were missing in the sciatic nerve paranodal regions (data not shown) in 4.1B Ϫ/Ϫ mutants. Quantification of the percentage of paranodes with a normal array of septa in the sciatic nerve of each genotype at 3 months revealed that, in the wild-type mice, 90% of paranodes contain a full complement of septa. In sciatic nerve fibers of 3-month-old ␤-Act-Cre;4.1B Flox mice, only 60% of the paranodes counted retained a full complement of septa, whereas 75% of paranodes in 3-month-old 4.1B Ϫ/Ϫ sciatic nerves contained a normal set of septa. In ␤-Act-Cre;4.1B Flox mice, paranodes often displayed severe morphological defects, which occluded visualization of missing septa suggesting that paranodal disorganization was more severe than were included in the quantification. Together, these results are consistent with our immunostaining results (Fig. 2) , which showed disrupted localization of the paranodal proteins in ␤-Act-Cre;4.1B Flox mutant sciatic nerve fibers. Next, we analyzed the spinal cord myelinated axons in 1-and 3-month-old wild type and ␤-Act-Cre;4.1B Flox mutants. As shown in Figure 6 A, wild-type spinal cord myelinated axons display a uniform arrangement of septa between the myelin loops and the axolemma (Fig. 6 A, arrowheads) . The fibers from 1-month-old ␤-Act-Cre;4.1B Flox mutant spinal cords revealed the presence of axoglial septa in some regions (Fig. 6 B, arrowhead) and complete loss of septa in other regions at the same paranodes (Fig. 6 B-D, asterisks) . In the areas in which septa are missing, the axolemma showed clear detachments from the myelin loops and loss of electron densities (Fig. 6 B-D, white arrows) . At 3 months, some electron densities are still found in ␤-Act-Cre;4.1B Flox mutant spinal cords (Fig. 6 F, arrowhead) . However, many paranodal loops were detached from the axonal membrane (Fig. 6 F, G,  arrows) . In addition, larger areas were found with missing septa (Fig. 6 H, white arrow) , and detached axolemma (Fig. 6G,H , asterisks). Detachment of paranodal loops abutting the node agrees with immunohistochemical data revealing gaps between the nodal proteins and Caspr in 4-month-old ␤-Act-Cre;4.1B Flox mutant spinal cords (Fig. 3Cd,Fd, arrowheads) . The ␤-Act-Cre; 4.1B Flox mutant fibers also revealed accumulation of smooth endoplasmic reticulum (SER) at the nodal/paranodal regions (Fig. 6 E) , suggesting a disruption of the local axonal cytoskeleton, as has been previously observed in Caspr, Cgt (Einheber et al., 2006; Garcia-Fresco et al., 2006) , and Nfasc NF155 (Pillai et al., 2009) mutants. These data suggest that 4.1B is not required for the initial organization of the paranodal axoglial septa, but for their stabilization.
To determine the paranodal defects in the spinal cord myelinated axons in 4.1B Ϫ/Ϫ mutants, we analyzed them at P90, 6 month, and 1 year time points. As shown in Figure 6 I, P90 wildtype spinal cord myelinated axons showed proper densities and arrangement of the septa (arrowheads). In contrast, P90 4.1B Ϫ/Ϫ mutants showed myelinated axons with normal septa (Fig. 6 J, arrowheads) and regions with abnormal or missing septa (Fig. 6 J, asterisks, white arrow). By 6 months, 4.1B Ϫ/Ϫ mutant myelinated axons revealed a more prominent loss of septa with increased spacing between the paranodal lateral loops and the axolemma, indicating a progressive deterioration of the paranode with age (Fig. 6 K, asterisks) . In these fibers, destabilization of septa becomes obvious as the densities of these fibers looked diffuse ( 6 K, arrowheads). Analysis of 1-year-old 4.1B Ϫ/Ϫ mutants spinal cord myelinated axons revealed additional destabilization of the paranodal regions, with essentially all septa lost and the axolemma detaching from the myelin loops (Fig. 6 L, M, asterisks) . The 1-year-old 4.1B Ϫ/Ϫ mutant spinal cord myelinated axons also revealed accumulation of organelles, including mitochondria and SER at the nodal/paranodal regions, suggesting a disruption of the axonal cytoskeleton, as observed in the sciatic nerves (Fig. 6 N, arrowheads) (data not shown). To directly compare the phenotypes in the two 4.1B-null mice, the number of paranodes with a complete set of septa at 3 months were quantified. In wild-type spinal cords, 94% of paranodes contain a full set of septa. In ␤-Act-Cre;4.1B Flox spinal cords, only 36% of the paranodes retain a complete set of septa, whereas 50% of the paranodes in 4.1B Ϫ/Ϫ spinal cords maintain a complete set of septa. Interestingly, in the spinal cord of ␤-Act-Cre;4.1B Flox mice, loss of septa resulted in destabilization of paranodal loops, especially in the region abutting the node (Fig. 6 F) . Quantification revealed that 72% of paranodes in wild-type spinal cords contain a complete set of loops contacting the paranodal axolemma. In the ␤-Act-Cre;4.1B Flox spinal cords, only 33% of paranodes maintained loops in contact with the axolemma. In comparison, in 4.1B Ϫ/Ϫ spinal cords, 71% of paranodes retained a complete set of loops contacting the axolemma. These data suggest that loss of 4.1B in ␤-Act-Cre;4.1B Flox spinal cords results in destabilization of the septa and lifting of the paranodal loops from the axolemma. Together, the ultrastructural analyses in ␤-Act-Cre; 4.1B Flox and 4.1B Ϫ/Ϫ mutants demonstrate that 4.1B is critical for the stabilization of paranodal AGSJs, and that the long-term stability of the AGSJs is dependent on 4.1B, as it provides a scaffolding link with the paranodal axonal cytoskeleton (Table 1) .
4.1R is not expressed at the PNS paranodes or enriched in 4.1B
؊/؊ mutants One of the underlying reasons suggested to explain a lack of phenotype at the PNS paranodes in 4.1B Ϫ/Ϫ mutants was that 4.1R was expressed at the mutant paranodes and not at the wildtype paranodes (Horresh et al., 2010) . We wanted to determine whether ␤-Act-Cre;4.1B Flox mutant sciatic nerves also had increased 4.1R expression at the paranodes, and as controls we used 4.1B Ϫ/Ϫ mutants. Immunostaining of wild-type (ϩ/ϩ), ␤-ActCre;4.1B Flox , and 4.1B Ϫ/Ϫ sciatic nerve fibers against 4.1R did not reveal expression of 4.1R at paranodes in any of the genotypes analyzed (Fig. 7Aa,c-Fa,c, red, arrowheads) . Caspr localization was normal in the wild-type and 4.1B Ϫ/Ϫ mutant fibers and disrupted in ␤-Act-Cre;4.1B Flox mutant fibers (data not shown). These data show that 4.1R is not expressed at the paranodes and thus cannot possibly compensate for loss of 4.1B at the paranodes. To test the specificity of our 4.1R antibody, we performed immunoblot analysis of sciatic nerves from wild-type and
4.1R
Ϫ/Ϫ mice and confirmed that 4.1R was missing in 4.1R
Ϫ/Ϫ sciatic nerves (Fig. 7G ) (Shi et al., 1999) . We also performed immunoblot analysis of sciatic nerves and spinal cords from littermate wild type and ␤-Act-Cre;4.1B Flox and 4.1B Ϫ/Ϫ mutants. As shown in Figure 7 , H and I, no significant differences, and especially no increases, were observed in 4.1R levels between wild type and both 4.1B mutants. Immunoblotting against Tub was used as a loading control. To confirm these results, we also completed RT-PCR with RNA extracted from dorsal root ganglia of littermate wild type and ␤-Act-Cre;4.1B Flox and 4.1B Ϫ/Ϫ mutants (Fig. 7J ) . Primers targeted to amplify DNA from exons 5 through 8 were used to show deletion of exon 6 in the ␤-Act-Cre;4.1B Flox mice (Fig. 7J ) . The genotype of 4.1B Ϫ/Ϫ mutants were confirmed using primers designed to exons 2 through 3, resulting in loss of the band in this mutant only (data not shown). Importantly, 4.1R levels were uniform in all genotypes (Fig. 7J ) . Actin was used as a housekeeping gene control. Together, the immunostaining, immunoblot, and RT-PCR analyses in two independent 4.1B mutants show that 4.1R is not expressed at the paranodes in the wild-type fibers and that 4.1R does not get enriched at 4.1B mutant paranodes (Table 1) .
Discussion
The organization of specialized membrane environments that create cellular diversification depends on linkage of cellular membranes with the underlying cytoskeleton (Jekely, 2007) . The 4.1 protein family functions to link the plasma membrane with the actin cytoskeleton (Cohen and Foley, 1982; Conboy, 1993; Hoover and Bryant, 2000; Sun et al., 2002; Chen et al., 2005) . In the nervous system, the cell adhesion molecules Caspr and Caspr2 contain 4.1-binding sites, which are required for their localization to the paranodes and juxtaparanodes, respectively (Poliak et al., 2003; Traka et al., 2003; Horresh et al., 2010) . When Caspr expression is genetically ablated, AGSJs fail to form, leading to loss of axonal domain segregation and disrupted paranodal axonal cytoskeleton (Bhat et al., 2001; Garcia-Fresco et al., 2006) , suggesting that paranodal AGSJs are linked to axonal cytoskeleton. In this study, phenotypic analyses of 4.1B mutants showed that 4.1B is required for the stability of paranodal AGSJs in myelinated axons.
Isoform-specific functions of 4.1B in PNS and CNS myelinated axons
Phenotypic analysis of ␤-Act-Cre;4.1B Flox mutant sciatic nerves showed paranodal defects as early as P30. The CNS paranodal defects at P30 were relatively mild, but at P90 transverse septa were often lost and paranodal loops were coming off the axolemma, indicating an important role for 4.1B in AGSJ stabilization. Phenotypic analysis of the previously reported 4.1B mutants (Yi et al., 2005) did not show disorganized Caspr localization or loss of paranodal septa in the PNS at P90, but revealed progressive destabilization of CNS paranodal septa at later stages of development. These variable phenotypes between 4.1B mutants could be attributed to the nature of 4.1B mutations, their genetic backgrounds, or the multiple splice isoforms of 4.1B. Strain genetic backgrounds could be a contributing factor to phenotypic discrepancies between the two 4.1B mutants. The 4.1B Ϫ/Ϫ mice are on a C57BL/6 background, whereas the ␤-Act-Cre;4.1B Flox mice are on a mixed background of C57BL/6 and 129SvEv. ␤-Act-Cre;4.1B Flox mice show a consistent phenotype throughout all mixed lines. We also examined the localization of 4.1B, Caspr, AnkG, K v 1.2, and NF186 in each background strain and did not observe any disruptions in the localization of these proteins or the morphology of the paranodes (data not shown). These results suggest that the paranodal phenotypes observed in ␤-Act-Cre;4.1B Flox mice are attributable to loss of 4.1B and not attributable to genetic background of the strains used.
In agreement with previous studies that showed two 4.1B isoforms in brain lysates (145 and 125 kDa) (DenisenkoNehrbass et al., 2003) , we also observed the same isoforms in the spinal cord. Differential alternative splicing in the PNS versus CNS may allow 4.1B to function in a tissue-specific manner. The expression of close to eight different isoforms in the PNS may explain the variation in phenotype seen between PNS and CNS, as well as the differences between ␤-Act-Cre; 4.1B Flox and 4.1B Ϫ/Ϫ mutants. The phenotypic differences may lie in the nature of the 4.1B mutations, as specific isoforms may play different roles in domain organization and stability in the CNS and the PNS. In 4.1B Ϫ/Ϫ mutants, exon 3 was disrupted by insertion of a puromycin resistance cassette (Yi et al., 2005) . It is possible that some compensatory isoforms or splice variants remain in 4.1B Ϫ/Ϫ mutants, which may not be detected by our antibodies directed to the U3 region of 4.1B, or by antibodies directed to the U2 region of 4.1B (Kang et al., 2009 ) (data not shown). We believe that our targeted deletion of a common exon 6, which encodes the middle portion of the FERM domain, generates a 4.1B-null mutation. Additional evidence for a 4.1B-null mutation lies in the paranodal disorganization phenotype displayed by ␤-Act-Cre;4.1B Flox compared with that observed in 4.1B Ϫ/Ϫ mutants, even at 1 year of age. In addition, our immunohistochemical, immunoblot, and RT-PCR analyses did not reveal juxtaparanodal components from entering paranodal space (Horresh et al., 2010) . Furthermore, Caspr with a deleted C-terminus can reach, but fails to stabilize at paranodes, suggesting that the C-terminus is essential for Caspr stabilization (Gollan et al., 2002) . Protein 4.1B likely stabilizes the paranodes through direct interactions with Caspr and other cytoskeletal proteins such as AnkB and ␣II-and ␤II-spectrin (Garcia-Fresco et al., 2006; Ogawa et al., 2006) . Interestingly, domain disorganization in 4.1B mutants did not result in conduction velocity differences in P30 wild-type, ␤-Act-Cre;4.1B Flox , or 4.1B Ϫ/Ϫ sciatic nerve fibers (data not shown). In addition, neither 4.1B mutants display obvious behavioral deficits, as of 4 months of age. However, precise electrophysiological recordings of individual axons and behavioral tests for motor function could reveal deficits in older 4.1B mutants.
The juxtaparanode is established by interactions between Caspr2 and TAG-1 (Poliak et al., 2003; Traka et al., 2003) . In this region, no axoglial junctions are formed, but a loose axoglial scaffold is established that moves toward the paranode in paranodal mutants (Dupree et al., 1999; Bhat et al., 2001; Boyle et al., 2001; Pillai et al., 2009 ). These findings suggest that the juxtaparanode is not anchored with axonal cytoskeleton even though Caspr2 also has 4.1B-binding sequences (DenisenkoNehrbass et al., 2003; Horresh et al., 2010) . The juxtaparanodal region clusters potassium channels, which are lost in Caspr2 and Tag-1 mutants (Poliak et al., 2003; Traka et al., 2003) . Interestingly, both the ␤-Act-Cre;4.1B Flox and 4.1B Ϫ/Ϫ mutants revealed disorganization of juxtaparanodal proteins, with loss of potassium channels and Caspr2 localization (Figs. 2, 3 ) (data not shown). This suggests that formation and/or stabilization of the juxtaparanodal axoglial scaffold critically depends on 4.1B, thus highlighting the role of axonal cytoskeletal adaptor proteins in the stability of axonal domains.
Evolutionary role of cytoskeletal proteins in stabilizing axoglial septate junctions
The founding member and Drosophila ortholog of the vertebrate Caspr family, Neurexin IV (Nrx IV), contains a 4.1-binding sequence in its C-terminus (Baumgartner et al., 1996; Bellen et al., 1998; Bhat, 2003 Bhat, , 2004 Banerjee et al., 2006a ). An ortholog of the vertebrate 4.1 family that colocalizes with Nrx IV at septate junctions is Coracle (Cora) (Fehon et al., 1994) . Null mutants of nrx IV and cora show mislocalization of Cora and Nrx IV, respectively, and fail to establish septate junctions (Fehon et al., 1994; Baumgartner et al., 1996; Lamb et al., 1998; Ward et al., 1998; Banerjee et al., 2006b ). Furthermore, mutations in the FERM domain of Cora disrupts its membrane localization, suggesting that the interaction between Cora and its transmembranebinding partners is required for localization of Cora at the membrane. Together, our data provide convincing evidence that 4.1B is critically required for proper maintenance of axonal domains in myelinated axons by acting as a molecular adaptor between membrane components at the paranodal and juxtaparanodal regions and the underlying axonal cytoskeleton. These interactions are central to the long-term stability of axonal domains and thus saltatory nerve conduction.
